Dugel Pravin
See Remarks
Dugel Pravin has filed 8 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 26, 2026.
On the most recent filing, Dugel Pravin is listed as See Remarks at OCULAR THERAPEUTIX, INC. Inside the rolling window, Dugel Pravin reported no open-market purchases and 5 open-market sales totaling $1.9M in OCUL. The largest disclosed transaction in the window is a sale of 124,882 OCUL shares on Feb 12, 2026, worth $1.1M.
Companies traded
Other insiders at OCUL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dugel Pravin made?
Dugel Pravin has filed 8 SEC Form 4 filings (17 transaction rows) across 1 company since 2025.
Which companies does Dugel Pravin trade?
Dugel Pravin has filed SEC Form 4 disclosures for 1 company, including OCUL.
When was Dugel Pravin's most recent SEC Form 4 filing?
Dugel Pravin's most recent SEC Form 4 filing on Tracefour is dated Aug 26, 2026.
What is Dugel Pravin's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dugel Pravin is listed as See Remarks.
What is Dugel Pravin's total buy and sell value in the current window?
Inside the rolling retention window, Dugel Pravin bought $0 and sold $1.9M based on SEC Form 4 filings.
What was Dugel Pravin's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 124,882 OCUL shares on 2026-02-12, worth $1.1M, per SEC Form 4 filings.